Pentamidine

ArtNr	HY-B0537-10mg
Hersteller	MedChem Express
CAS-Nr.	100-33-4
Menge	10 mg
Quantity options	100 mg 10 mg 1 ea 25 mg 50 mg 5 mg
Kategorie	Oncology Inhibitors & Compound Libraries Small Molecules By Organ Lung Cancer Skin Cancer Colorectal Cancer
Typ	Inhibitors
Specific against	other
Purity	97.19
Citations	[1]Pathak MK, et al. Pentamidine is an inhibitor of PRL phosphatases with anticancer activity. Mol Cancer Ther. 2002 Dec;1(14):1255-64.\|[2]Nguewa, P.A., et al., Pentamidine is an antiparasitic and apoptotic drug that selectively modifies ubiquitin. Chem Biodivers, 2005. 2(10): p. 1387-400.\|[3]Sands M, et al. Pentamidine: a review. Rev Infect Dis. 1985 Sep-Oct;7(5):625-34.\|[4]David C. Bean, et al. Pentamidine: a drug to consider re-purposing in the targeted treatment of multi-drug resistant bacterial infections? J Lab Precis Med 2017;2:49. Biochem Biophys Res Commun. 2019 Sep 17;517(2):221-226.\|BMC Womens Health. 2022 Nov 24;22(1):470.\|Drug Des Dev Ther. 2021 Jul 1;15:2857-2868.\|Immunity. 2023 Feb 14;56(2):272-288.e7.\|Int J Mol Sci. 2023 Sep 5, 24(18), 13812.\|Microbiol Spectr. 2023 May 1;e0313822.\|Molecules. 2020 Apr 23;25(8):1980.\|Cell Rep Methods. 2023 Oct 23;3(10):100599.
Smiles	N=C(C1=CC=C(OCCCCCOC2=CC=C(C(N)=N)C=C2)C=C1)N
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	MP-601205
Versandbedingung	Raumtemperatur
Lieferbar
Manufacturer - Type	Reference compound
Manufacturer - Applications	COVID-19-immunoregulation
Manufacturer - Targets	Antibiotic; Bacterial; Fungal; Parasite; Phosphatase
Shipping Temperature	Room Temperature
Storage Conditions	4°C (Powder, protect from light)
Molecular Weight	340.42
Product Description	Pentamidine (MP-601205) is an antimicrobial agent and interferes with DNA biosynthetics. Pentamidine inhibits parasite Leishmania infantum with an IC50 of 2.5 μM. Pentamidine is a potent and selective protein tyrosine phosphatases (PTPases) and phosphatase of regenerating liver (PRL) inhibitor. Pentamidine has the potential for Gambian trypanosomiasis, antimony-resistant leishmaniasis, and Pneumocystis carinii pneumonia treatment. Antitumor and antibacterial activities[1][2][3][4].
Manufacturer - Research Area	Cancer; Infection
Solubility	DMSO: 3.3 mg/mL (ultrasonic; warming; adjust pH to 6 with 1 M HCl; heat to 60°C)
Manufacturer - Pathway	Anti-infection; Metabolic Enzyme/Protease
Isoform	Leishmania; Trypanosoma
Clinical information	Launched

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Arbeitsanleitung (Data Sheet) anfordern

Produkt-Datenblatt anfordern

HY-B0537-10mg-safety-datasheet.pdf